LXRX Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas.

$4.59  +0.01 (0.22%)
As of 09/17/2021 11:07:37 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/23/2001
Outstanding shares:  144,474,452
Average volume:  1,236,407
Market cap:   $655,914,012
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    528872302
ISIN:        US5288723027
Sedol:      BWFZX59
Valuation   (See tab for details)
PE ratio:   17.38
PB ratio:   4.82
PS ratio:   92.46
Return on equity:   27.75%
Net income %:   536.83%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy